BioNTech SE (BNTX) Long-Term Investments (2021 - 2025)

BioNTech SE has disclosed Long-Term Investments across 5 years of filings, most recently posting $87.8 million for Q3 2025.

• Long-Term Investments for Q3 2025 came in at $87.8 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $87.8 million (changed N/A YoY), and the FY2023 annual result was $1.2 billion, up 561.12% from the prior year.
• Long-Term Investments came in at $87.8 million for Q3 2025 at BioNTech SE, down from $101.9 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.2 billion in Q4 2023 to a low of $24.4 million in Q4 2021.
• The 5-year median for Long-Term Investments is $101.9 million (2025), against an average of $220.0 million.
• Across the five-year window, Long-Term Investments jumped 637.76% in 2022 and tumbled 73.49% in 2025, its largest moves.
• BioNTech SE's Long-Term Investments stood at $24.4 million in 2021, then surged by 637.76% to $179.8 million in 2022, then surged by 561.12% to $1.2 billion in 2023, then tumbled by 79.77% to $240.4 million in 2024, then tumbled by 63.48% to $87.8 million in 2025.
• The last three Long-Term Investments figures came in at $87.8 million (Q3 2025), $101.9 million (Q2 2025), and $63.7 million (Q1 2025), per Business Quant data.